Drug intelligence / Profile preview

trihexyphenidyl

Development stage
Approved
Lead developer
Pfizer
Modality
Small Molecules
Administration
Oral
01

Overview

Trihexyphenidyl is a centrally acting antimuscarinic (anticholinergic) small molecule used primarily to manage symptoms of Parkinson's disease, including stiffness, tremors, spasms, and poor muscle control. It is also indicated for the treatment and prevention of extrapyramidal symptoms caused by certain antipsychotic medications. The drug works by antagonizing muscarinic acetylcholine receptors in the central nervous system, thereby reducing cholinergic activity that contributes to motor dysfunction. While it can provide symptomatic relief—especially for tremor—it does not cure Parkinson’s disease and is generally considered adjunctive therapy due to its side effect profile. Other uses include management of dystonia in children with cerebral palsy, essential tremor, akathisia, and as an antidote in organophosphate poisoning[1][2][4][5][6].

Brand names
ArtaneTrihexane
Other names
benzhexoltrihextrihexyphenidyl hydrochlorideTrihexifenidiloTrihexyphénidyleTrihexyphenidylum
02

Targets

NMDAR (Glutamate receptor ionotropic, NMDA)CHRNA7 (α7 nicotinic receptor)mAChR (Muscarinic acetylcholine receptors)

Beyond the preview

Go deeper on trihexyphenidyl.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on trihexyphenidyl.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call